np event 2254995 0E193A 1 1
Sunday, September 7th, 2025
11:30am – 12:00pm EDT
Therapeutic Update on COPD with Type 2 Inflammation
CME Symposium at the 2025 Eastern Pulmonary Conference

Date/Time

Sunday, September 7th, 2025
11:30am – 12:00pm EDT

Location

The Breakers Palm Beach
Ponce de Leon 4
1 S County Rd
Palm Beach, FL 33480

Who Should Attend

Pulmonologists and other healthcare professionals involved in the treatment and management of patients with COPD

Accreditation Statement

Joint

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Financial Support

This activity has been supported by an independent educational grant from GSK.

Faculty

Hanania (1)
Nicola A. Hanania, MD, MS, FRCP(C), FCCP, FERS, AT...
Professor of Medicine
Director, Airways Clinical Research Center
Baylor College of Medicine
Chief, Pulmonary and Critical Care Medicine
Ben Taub Hospital
Houston, TX

Event Details

CE Inquiries/Special Needs

Provided by

AcademicLogo
1

Describe updates to the latest iteration of GOLD guidelines that outline optimal diagnostic and treatment procedures for individuals with type 2 eosinophilic COPD

2

Assess the efficacy, safety, and mechanisms of action of newly approved and emerging pharmacotherapy for patients with type 2 eosinophilic COPD

3

Select the most appropriate therapeutic strategy for patients with type 2 eosinophilic COPD on the basis of relevant clinical factors

Faculty

Hanania (1)
Nicola A. Hanania, MD, MS, FRCP(C), FCCP, FERS, AT...
Professor of Medicine
Director, Airways Clinical Research Center
Baylor College of Medicine
Chief, Pulmonary and Critical Care Medicine
Ben Taub Hospital
Houston, TX
1

Case Presentation 1: Patient with a One-Year History of COPD, Adherent to Treatment, with Two Recent Exacerbations Resulting in ER Visits 

  1. Review of patient data and biomarkers
  2. Analysis of emerging and approved COPD therapeutics
  3. New GOLD Guideline-driven treatment plan options 
2

Case Presentation 2: Patient with Ten-Year History of COPD, Worsening Pulmonary Function, Referred to Academic Pulmonologist for Reassessment

  1. Update on recent clinical trial data for COPD therapeutics
  2. Long-term treatment plans for combination therapies and IL5 inhibitor therapeutics

Faculty

Hanania (1)
Nicola A. Hanania, MD, MS, FRCP(C), FCCP, FERS, AT...
Professor of Medicine
Director, Airways Clinical Research Center
Baylor College of Medicine
Chief, Pulmonary and Critical Care Medicine
Ben Taub Hospital
Houston, TX

Event Registration